Lakeshore Hospital Annual Reports, Balance Sheet and Financials

 

Lakeshore Hospital And Research Centre Limited Balance Sheet (Rs in Lakhs)

Particulars	31/03/2024	31/03/2023
ASSETS
Non-current assets
Property, Plant and Equipment	34,595.78	32,764.38
Capital work-in-progress	189.46	567.26
Other Intangible assets	111.01	44.09
Right-of-use assets	366.99	423.4
Other financial assets	1,602.83	1,321.66
Non-current tax assets (net)	953.69	458.65
Other non-current assets	585.34	155.15
Current assets
Inventories	1,070.93	1,271.85
Trade receivables	2,687.14	1,998.89
Cash and cash equivalents	993.28	3,663.15
Bank balances other than cash	6,672.41	6,178.19
Loans	2.48	5.58
Other financial assets	675.32	986.13
Other current assets	261.11	187.33
Total Assets	50,767.77	50,025.71
Equity and Liabilities
Equity
Equity Share capital	10,000.00	10,000.00
Other Equity	30,022.23	27,344.92
Total Equity	40,022.23	37,344.92
Non-current liabilities
Borrowings	-	723.56
Lease liabilities	361.15	427.46
Provisions	1,219.83	1,102.09
Deferred tax liabilities (Net)	1,736.73	1,980.75
Other non-current liabilities	565.12	327.02
Current liabilities
Borrowings	2.65	578.85
Lease liabilities	66.94	54.47
Trade payables
Total outstanding dues of micro enterprises and small enterprises	267.02	106.11
Total outstanding dues of creditors other than micro enterprises and small enterprises	3,012.47	3,433.27
Other financial liabilities	2,979.80	3,521.04
Other current liabilities	420.92	318.21
Provisions	112.91	107.96
Total Equity and Liabilities	50,767.77	50,025.71

 Lakeshore Hospital And Research Centre Limited Profit & Loss Statement (Rs in Lakhs)

Particulars	31/03/2024	31/03/2023
Revenue from operations	39,622.01	41,918.42
Other income	666.89	535.62
Total Income	40,288.90	42,454.04
Expenses:
Purchase of Medicines & Consumables	11,132.09	11,170.49
Changes in inventories of Medicines & Consumables	200.92	-165.7
Employee benefits expense	7,506.38	6,383.50
Finance costs	92.65	211.01
Depreciation and amortisation expense	2,369.92	2,269.19
Other expenses	13,487.10	14,344.09
Total expenses	34,789.06	34,212.58
Profit before tax	5,499.84	8,241.46
Tax expense:
Current tax	1,352.40	2,660.93
Tax for earlier years	0.87	17.09
Deferred tax	-240.68	-188.44
Profit for the year	4,387.25	5,751.88
Other comprehensive income
Items that will not be reclassified to profit or loss
Remeasurements of post employment benefit obligations	-13.28	-39.76
Income tax relating to items that will not be reclassified to profit or loss	3.34	11.58
Total other comprehensive income for the year	-9.94	-28.18
Total Comprehensive Income for the year	4,377.31	5,723.70
Earnings per equity share of Rs 10 each:
Basic	4.39	5.75
Diluted	4.39	5.75

Lakeshore Hospital And Research Centre Limited Consolidated Cash Flow Statement (Rs in Lakhs)

Particulars	31/03/2024	31/03/2023
Cash flow from operating activites
Profit before tax	5,486.56	8,201.70
Adjustments
Depreciation and amortisation	2,369.92	2,269.19
Interest expense	92.65	211.01
Interest income	-532.83	-416.18
Net (Profit)/ Loss on sale/write off of Property Plant and Equipment	-7.72	67.08
Government grant income	-43.36	-37.44
Bad debts and advances written off	-	-
Provision for doubtful debts	10.93	1,098.86
Operating cash flow before working capital changes	7,376.15	11,394.22
Movements in working capital :
(Increase) / decrease in inventories	200.92	-165.7
(Increase) / decrease in trade and other receivables	-1,275.99	-2,872.51
Increase / (decrease) in trade and other payables	-40.91	-876.04
	6,260.17	7,479.97
Direct taxes paid net of refunds	-1,848.31	-1,983.24
Net cash flows from operating activities	4,411.86	5,496.73
Cashflow from investing activities
Additions to Property, Plant & Equipment (including capital work in progress)	-4,555.83	-903.62
Investment in subsidiaries	-	-
Sale or withdrawal of property, plant and equipment	51.62	9.19
Interest received	574.38	229.75
Net cash flows from investing activites	-3,929.83	-664.68
Cashflow from financing activities
Proceeds/(Repayment) of Buyers credit/ Term Loan	-1,302.41	-577.39
Movement in Short term borrowings (Net)	2.65	-
Dividend paid	-1,696.26	-1,500.67
Payment of lease liabilities	-91.88	-83.86
Interest paid	-64.01	-169.34
Net cash flows from financing activities (C)	-3,151.91	-2,331.26
Net Increase in Cash & Cash Equivalents (A)+(B)+(C)	-2,669.88	2,500.79
Cash and cash equivalent at the beginning of the Year	3,663.15	1,162.36
Cash and cash equivalent at the end of the Year
Cash on hand	23.87	23.22
Balance with Banks in current account and deposit account	969.4	3,639.93
Cash and cash equivalents	993.27	3,663.15
Net increase/(decrease) in Cash and Cash equivalents	-2,669.88	2,500.79

Here is a summary of the Cash Flow Statement for the years 2024 and 2023:

Cash Flow from Operating Activities

Profit before tax:

2024: ₹5,486.56 million

2023: ₹8,201.70 million

The profit before tax decreased significantly in 2024 compared to 2023, which indicates lower profitability or higher expenses.

Adjustments:

Depreciation and amortization:

2024: ₹2,369.92 million

2023: ₹2,269.19 million

Depreciation and amortization increased, suggesting more capital assets are being depreciated.

Interest expense:

2024: ₹92.65 million

2023: ₹211.01 million

The interest expense decreased, which could mean reduced borrowing or lower interest rates.

Interest income:

2024: ₹-532.83 million

2023: ₹-416.18 million

Interest income increased negatively, indicating either higher interest expenses or lower interest earnings.

Net (Profit)/ Loss on sale/write-off of Property, Plant and Equipment:

2024: ₹-7.72 million

2023: ₹67.08 million

In 2024, there was a loss on the sale or write-off of assets, whereas in 2023, there was a gain.

Government grant income:

2024: ₹-43.36 million

2023: ₹-37.44 million

Slight increase in government grants received, which is a small positive adjustment.

Bad debts and advances written off:

2024 & 2023: ₹0 million

No bad debts were written off, indicating good debt collection practices.

Provision for doubtful debts:

2024: ₹10.93 million

2023: ₹1,098.86 million

A significant decrease in provisions, which might indicate improved credit control or a reduction in anticipated bad debts.

Operating cash flow before working capital changes:

2024: ₹7,376.15 million

2023: ₹11,394.22 million

Operating cash flow before working capital changes decreased, reflecting lower profitability or higher adjustments.

Movements in working capital:

Increase/ (decrease) in inventories:

2024: ₹200.92 million

2023: ₹-165.7 million

An increase in inventories suggests more capital is tied up in stock.

Increase/ (decrease) in trade and other receivables:

2024: ₹-1,275.99 million

2023: ₹-2,872.51 million

A decrease in receivables is positive, meaning faster collection of payments.

Increase/ (decrease) in trade and other payables:

2024: ₹-40.91 million

2023: ₹-876.04 million

A smaller decrease in payables compared to the previous year.

Net cash flows from operating activities:

2024: ₹4,411.86 million

2023: ₹5,496.73 million

Net cash flow from operating activities decreased, primarily due to lower profit before tax and changes in working capital.

Cash Flow from Investing Activities

Additions to Property, Plant & Equipment:

2024: ₹-4,555.83 million

2023: ₹-903.62 million

Significant increase in capital expenditure, suggesting heavy investment in assets or expansion.

Investment in subsidiaries:

No transactions in both years.

Sale or withdrawal of property, plant, and equipment:

2024: ₹51.62 million

2023: ₹9.19 million

Increase in proceeds from asset sales.

Interest received:

2024: ₹574.38 million

2023: ₹229.75 million

Substantial increase in interest income, indicating better returns on investments or increased interest-bearing assets.

Net cash flows from investing activities:

2024: ₹-3,929.83 million

2023: ₹-664.68 million

Cash outflow increased significantly due to higher investments in assets.

Cash Flow from Financing Activities

Proceeds/ (Repayment) of Buyers credit/ Term Loan:

2024: ₹-1,302.41 million

2023: ₹-577.39 million

Increased repayment of loans or reduced borrowing.

Movement in short-term borrowings (Net):

2024: ₹2.65 million

2023: ₹0 million

Minimal changes in short-term borrowings.

Dividend paid:

2024: ₹-1,696.26 million

2023: ₹-1,500.67 million

Increase in dividends paid, reflecting possibly higher shareholder payouts.

Payment of lease liabilities:

2024: ₹-91.88 million

2023: ₹-83.86 million

Slight increase in lease payments.

Interest paid:

2024: ₹-64.01 million

2023: ₹-169.34 million

Decrease in interest payments, consistent with reduced borrowings.

Net cash flows from financing activities:

2024: ₹-3,151.91 million

2023: ₹-2,331.26 million

Increased cash outflows from financing activities, reflecting higher repayments and dividend payments.

Net Increase/(Decrease) in Cash & Cash Equivalents

2024: ₹-2,669.88 million

2023: ₹2,500.79 million

The cash and cash equivalents decreased, mainly due to high investing and financing outflows.

Cash and Cash Equivalent at the Beginning of the Year:

2024: ₹3,663.15 million

2023: ₹1,162.36 million

Cash and Cash Equivalent at the End of the Year:

2024: ₹993.27 million

2023: ₹3,663.15 million

Significant reduction in cash reserves.

Financial Ratios of Lakeshore Hospital And Research Centre Limited

Particulars	2023-24	2022-23
Current ratio	1.8	1.76
Debt- equity ratio	0	0.03
Debt Service Coverage Ratio	42.17	9.83
Return on equity	0.11	0.16
Inventory Turnover Ratio	9.67	9.26
Trade Receivable turnover ratio	16.91	20.89
Trade Payables Turnover	3.27	3.26
Net Capital Turnover	7.2	6.79
Net Profit/(Loss) Margin	0.11	0.14
Return on Capital employed	0.14	0.22

Here is a summary of the financial and operational metrics for Lakeshore Hospital And Research Centre Limited for the years 2024 and 2023:

Current Ratio

2023-24: 1.8

2022-23: 1.76

Insight: The current ratio has improved slightly, indicating a marginal increase in the company 's ability to meet its short-term liabilities with its short-term assets. A ratio above 1 generally suggests good short-term financial health.

Debt-Equity Ratio

2023-24: 0

2022-23: 0.03

Insight: The debt-equity ratio has dropped to zero, suggesting that the company has eliminated its debt or significantly reduced it compared to the previous year. This indicates a lower financial risk and a more conservative approach to leveraging.

Debt Service Coverage Ratio (DSCR)

2023-24: 42.17

2022-23: 9.83

Insight: The DSCR has increased dramatically, indicating a substantial improvement in the company 's ability to cover its debt obligations with its operating income. This improvement reflects stronger financial stability and a higher capacity to service debt.

Return on Equity (ROE)

2023-24: 0.11 (11%)

2022-23: 0.16 (16%)

Insight: The ROE has decreased, which means the company is generating less profit per unit of shareholders ' equity. This decline may suggest reduced profitability or increased equity base without a corresponding increase in net income.

Inventory Turnover Ratio

2023-24: 9.67

2022-23: 9.26

Insight: The inventory turnover ratio has improved, indicating a more efficient use of inventory. The company is selling and replenishing its inventory slightly faster, which can positively impact cash flow and reduce holding costs.

Trade Receivable Turnover Ratio

2023-24: 16.91

2022-23: 20.89

Insight: The decrease in this ratio suggests that the company is taking longer to collect payments from its customers. This could affect cash flow and may indicate potential issues with credit control or slower payment by customers.

Trade Payables Turnover Ratio

2023-24: 3.27

2022-23: 3.26

Insight: The ratio has remained relatively stable, indicating consistent efficiency in paying suppliers. A stable payables turnover ratio reflects steady management of supplier payments.

Net Capital Turnover

2023-24: 7.2

2022-23: 6.79

Insight: The net capital turnover ratio has increased, showing that the company is generating more revenue per unit of net capital employed. This indicates improved efficiency in utilizing capital to generate sales.

Net Profit Margin

2023-24: 0.11 (11%)

2022-23: 0.14 (14%)

Insight: The net profit margin has decreased, which indicates a reduction in profitability relative to sales. This could be due to higher costs, lower sales prices, or other factors affecting profit margins.

Return on Capital Employed (ROCE)

2023-24: 0.14 (14%)

2022-23: 0.22 (22%)

Insight: The ROCE has declined, suggesting that the return generated from capital employed has reduced. This could be a result of lower profitability or increased capital investment without a proportional increase in profit.

 Dividend History

Particulars	2024	2023
Dividend Per Share (in Rs.)	1.7	1.7
Retained Earnings (Rs. In Lakhs)	15,522.23	12,844.92

 Lakeshore Hospital And Research Centre Limited Recent Financial Performance

Dividend per Share: The specific dividend per share figure for 2024 and 2023 is Rs 1.7 and Rs 1.7. Dividend per share represents the portion of a company 's earnings that is distributed to shareholders in the form of dividends. A higher dividend per share may indicate that the company is sharing more of its profits with shareholders.

Retained Earnings: Retained earnings for 2024 amounted to Rs 15522.23 Lakhs, while in 2023, they were Rs. 12844.92 Lakhs. Retained earnings represent the portion of a company 's profits that is reinvested in the business rather than distributed as dividends. An increase in retained earnings suggests that the company has retained more of its profits for reinvestment or future growth.

To provide a more comprehensive analysis, it would be necessary to consider additional financial metrics such as revenue, net profit, assets, liabilities, and cash flows. Additionally, an analysis of trends over multiple years and a comparison to industry benchmarks and competitors would help in assessing the company 's financial health and performance